Publications > Population Briefs > HIV and AIDS: Microbicides


Population Briefs June 2004

HIV and AIDS
Microbicides 

2004

  • Biomedical Research
    Carraguard May Block HIV by Adhering to Cells
    HIV may be ferried deep into the body from the vagina by immune system cells known as macrophages, suggests new research conducted by Population Council virologist David M. Phillips and his colleagues. The research also showed that the Council’s lead candidate microbicide gel, Carraguard®, is effective at reducing this form of HIV transmission in lab animals. The Population Council is preparing to enter into large-scale clinical trials to test Carraguard’s efficacy in blocking HIV transmission in 4,000 nonpregnant women. The microbicide candidate will be one of the first products of its kind to enter this advanced phase of research. 

2002

  • Microbicides
    Motivations for and Barriers to Study Participation
    To gain insight into the factors that motivate people to participate in clinical trials, Population Council researchers with colleagues at the Thailand Ministry of Public Health–U.S. Centers for Disease Control and Prevention Collaboration recently assessed the interests and concerns of women in Chiang Rai, Thailand regarding participation in microbicide clinical trials. Findings from this and similar research may prove valuable for selecting trial sites, estimating enrollment rates, and tailoring trials to best meet women’s needs.  

2001

  • Biomedical Research
    Nonoxynol-9 Rapidly Exfoliates Rectal Epithelium
    New findings suggest that products containing the spermicide nonoxynol-9 (N-9) may increase the risk of HIV infection when used during rectal intercourse. David M. Phillips, of the Population Council's Center for Biomedical Research, and his colleagues found that N-9 caused the rapid shedding of epithelium when applied rectally. Surveys in the United States have shown that 41 percent of men who have sex with men try to use products containing N-9 as lubricants during rectal sex. This practice stems in part from a belief that such products may protect against HIV infection. While there is some evidence in support of this idea, there is also some evidence that N-9 may enhance HIV transmission. 



Print this page

@
E-mail this page

This page updated
10 October 2007